CINCINNATI, Ohio — Donuts have a way of pleasing the senses. Chocolate, blueberry, glazed – you can almost taste them just by looking at them. What if you couldn't see the wide selection? Cheri ...

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older. It affects the central portion of the retina, called the macula.

The trial is funded through Abu Dhabi’s Healthcare Research and Innovation FundClinical development activities will commence ...

Eyestem Research Pvt Ltd, a biotechnology company developing advanced scalable cell therapy solutions for blindness caused by dry age-related macular degeneration, has received ...

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have been no FDA-approved (or other) treatments to slow or stop vision loss. That ...

A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...

The UC Davis Department of Ophthalmology has received a five-year, $3.6 million grant from the National Eye Institute to explore a new way to treat vision loss using gene therapy. The research could ...

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older. Subscribe to our newsletter for the latest sci-tech news updates.